Advancing precision oncology in breast cancer: the FDA approval of elacestrant and Guardant360 CDx: a correspondence

por Abbasi, Haleema Qayyum, Maryyum, Adeena, Khan, Abdul Moiz, Shahnoor, Syeda, Oduoye, Malik O., Wechuli, Polyne N.
Publicado 2023